Switch to optionsXpress for advanced derivatives trading & earn 50 commission-free trades.
SureTrader Stock Hero Advertisement
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator biovalidator, KingDMC
Search This Board:
Last Post: 3/25/2015 10:19:12 PM - Followers: 380 - Board type: Free - Posts Today: 0

Logo: Inovio




ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE- http://www.youtube.com/watch?v=95yO6hFpbUM

Float: 97.65 M

Shares Outstanding: 127.26 M

Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.

Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
INO News: Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers 12/18/2014 06:00:00 AM
INO News: Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology 12/17/2014 08:00:00 AM
INO News: Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 12/15/2014 08:00:00 AM
INO News: Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bac... 10/21/2014 06:00:00 AM
INO News: Inovio Pharmaceuticals Appoints Vice President of Commercial Development 09/30/2014 07:00:00 AM
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#12877   Added today harry crumb 03/25/15 10:19:12 PM
#12876   Yes us to harry crumb 03/24/15 08:54:21 AM
#12875   Thanks. This has been a good one to cracity 03/24/15 08:14:14 AM
#12874   Nice congrats, profits!! harry crumb 03/24/15 12:37:03 AM
#12873   I was buying from $8s all the way cracity 03/23/15 10:05:15 AM
#12871   Inovio, one of my investments, has a process nanopatent 03/21/15 11:14:26 AM
#12870   New article on INO: someconcerns 03/20/15 08:15:54 PM
#12869   Buy the dips, we should see 12 area next harry crumb 03/20/15 10:52:27 AM
#12868   $10 INO! KingDMC 03/20/15 09:59:20 AM
#12867   10 it is! Again. We loaded 6's- 7's, harry crumb 03/20/15 09:56:21 AM
#12866   Great article, thanks much for posting. CHM_760 03/20/15 09:08:15 AM
#12865   http://fusion.net/story/57515/darpa-thinks-it-has-a-solution-to-ebola-and-all-ot pmgtrader 03/19/15 11:15:09 PM
#12864   Great day here, back ovr 10 soon. Hope harry crumb 03/19/15 03:32:48 PM
#12863   You Can’t Stop Rock ’n’ Roll! MRatt 03/19/15 01:43:27 PM
#12862   Loving the action tho! KingDMC 03/19/15 01:17:41 PM
#12861   Where she stops, no body knows! KingDMC 03/19/15 01:13:54 PM
#12860   Nice run last few days. Where is the top? cracity 03/19/15 12:53:18 PM
#12859   Rally mode I love it! KingDMC 03/19/15 10:54:01 AM
#12858   Turned Green! cracity 03/17/15 03:27:39 PM
#12857   Nice recovery so far as the DOW tumbles..... cracity 03/17/15 12:25:08 PM
#12856   I figured shorts would enact their revenge today. cracity 03/17/15 09:41:10 AM
#12855   Are you shorting this or long? Tate 03/17/15 08:40:30 AM
#12854   * * $INO Video Chart 03-16-15 * * ClayTrader 03/16/15 04:59:31 PM
#12853   Nice day. Can the momentum continue into tomorrow? cracity 03/16/15 04:08:37 PM
#12852   +20% KingDMC 03/16/15 03:26:45 PM
#12851   $8.20 +16% KingDMC 03/16/15 01:26:12 PM
#12850   INO is back! KingDMC 03/16/15 09:51:54 AM
#12849   Inovio Pharmaceuticals and Academic Collaborators Receive $16 Million KingDMC 03/16/15 09:51:45 AM
#12848   Regulatory clearance INO 5150. NO delay 1H2015. Tate 03/16/15 09:04:07 AM
#12847   Inovio Pharmaceuticals (NASDAQ:INO): Q4 EPS of -$0.12 misses KingDMC 03/16/15 06:56:19 AM
#12846   Let's run it up to 11 again. This Bunk 03/16/15 05:16:50 AM
#12845   'sharpei Friday, 02/13/15 07:57:35 AM sharpei 03/15/15 06:41:50 PM
#12844   Yes! All I have to contribute are my faint hopes!! nanopatent 03/15/15 03:41:22 PM
#12843   Haha! These types of threads get out Peterconway13 03/15/15 02:13:35 PM
#12842   Realistically? nanopatent 03/15/15 10:27:36 AM
#12841   Realistically...where do we see the pps going if Peterconway13 03/14/15 07:47:07 PM
#12840   HC Wainright Initiates Coverage on Inovio Pharmaceuticals (INO) nanopatent 03/14/15 09:35:02 AM
#12839   Agree, been here LONG time, whatever happened to Tate 03/13/15 05:56:05 PM
#12838   Have never felt I was stuck with INO billmick11 03/13/15 05:01:37 PM
#12837   How many of u are stuck with Ino ? Bunk 03/13/15 04:53:55 PM
#12836   4th Qtr earnings scheduled before bell Monday 3/16, Tate 03/13/15 01:09:40 PM
#12835   H.C. Wainwright Starts Inovio Pharmaceuticals (INO) at Buy, Lolaspike 03/12/15 07:40:20 AM
#12834   CEO aggressively buying and holding. Great platform though Adi2 03/10/15 02:24:28 PM
#12833   Form 4's, buying here! harry crumb 03/10/15 10:51:51 AM
#12832   I hope you took advantage of that, giving cracity 03/09/15 01:03:21 PM
#12831   Get these 7's, we are!! harry crumb 03/09/15 11:56:40 AM
#12830   Big gains already from last week harry crumb 03/05/15 11:01:16 AM
#12829   Hope so cracity 03/05/15 10:28:21 AM
#12828   Told everyone ino will gap up, even the harry crumb 03/05/15 10:17:38 AM
#12827   Let'r run! cracity 03/04/15 03:47:07 PM